7Baggers

China Pharma Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -18.75-15.53-12.31-9.1-5.88-2.660.553.77Milllion

China Pharma Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2004-06-30 2004-03-31 2003-12-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 2002-09-30 2002-06-30 2002-03-31 2001-12-31 2001-09-30 
  revenue2,149,686 1,803,461 1,097,862 1,960,290 2,921,000 1,965,931 1,613,156 1,604,005 2,889,368 1,978,627 2,415,559 2,358,371 2,931,104 2,400,667 3,770,723 1,763,955 3,048,411 2,376,844 2,569,408 2,929,273 3,242,820 2,298,472 3,173,711 3,615,684 3,847,709 3,162,222 2,917,180 3,285,203 5,262,194 3,125,596 3,542,230 3,640,494 4,503,412 4,479,113 5,674,175 5,694,930 3,331,264 5,566,543 6,130,544 7,105,515 8,414,367 8,116,599 8,026,325 8,249,387 11,645,571 12,176,344 14,598,403 16,086,731 22,458,605 20,987,725 19,600,852 18,119,557 23,973,926 18,680,390 16,631,354 15,102,510 19,580,330 15,522,953 13,601,355 12,991,982 15,362,170 12,610,642 11,278,803 11,717,045 9,088,803 8,293,497 8,570,256 7,233,768 8,121,675 5,015,272 3,975,569 4,732,991 5,560,000 2,590,507 -2,500 18,458 2,500 4,817 14,725 5,079 3,850 86,425 1,370 8,624 24,614 2,882 
  cost of revenue2,291,102 2,036,651 1,244,523 1,782,366 2,878,318 2,103,687 1,842,537 1,773,466 2,587,432 2,275,023 2,344,559 2,085,640 2,369,631 2,353,471 2,620,925 1,569,516 2,759,064 2,004,085 2,405,860 2,272,743 3,413,698 1,785,927 2,594,230 2,561,984 3,166,908 2,740,683 2,268,823 2,567,350 3,516,568 2,775,628 3,060,133 2,999,675 4,364,151 4,157,113 5,730,002 4,635,803 7,249,950 4,057,480 3,713,147 4,445,129 8,013,788 5,879,334 5,876,180 9,818,295 10,255,815 8,932,552 10,460,047 10,782,384 15,137,062 13,472,804 12,318,868 11,249,946 14,494,474 11,055,254 9,587,417 8,968,302 12,322,104 8,979,083 7,681,845 7,063,227 7,948,213 6,494,266 5,325,992 5,909,768 4,600,614 4,413,042 4,670,685 3,934,849 4,593,917 2,521,205 2,105,082 2,526,020 2,230,000 1,613,840 5,546 12,430 38,329 39,568 14,822 
  gross profit-141,416 -233,190 -146,661 177,924 42,682 -137,756 -229,381 -169,461 301,936 -296,396 71,000 272,731 561,473 47,196 1,149,798 194,439 289,347 372,759 163,548 656,530 -170,878 512,545 579,481 1,053,700 680,801 421,539 648,357 717,853 1,745,626 349,968 482,097 640,819 139,261 322,000 -55,827 1,059,127 -3,918,686 1,509,063 2,417,397 2,660,386 400,579 2,237,265 2,150,145 -1,568,908 1,389,756 3,243,792 4,138,356 5,304,347 7,321,543 7,514,921 7,281,984 6,869,611 9,479,452 7,625,136 7,043,937 6,134,208 7,258,226 6,543,870 5,919,510 5,928,755 7,413,957 6,116,376 5,952,811 5,807,277 4,488,189 3,880,455 3,899,571 3,298,919 3,527,758 2,494,067 1,870,487 2,206,971 3,330,000 976,667 -8,046 6,028 2,500 4,817 14,725 -33,250 -35,718 71,603 1,370 8,624 24,614 2,882 
  operating expenses                                                                                      
  research and development147,552 45,773 23,747 23,008 27,999 88,747 15,063 54,049 54,048 21,374 53,456 190,086 261,473 37,628 30,044 48,819 53,995 39,716 66,008 69,918 64,438 62,059 23,674 22,213 15,421 27,543 21,450 26,060 76,780 99,095 96,661 93,433 220,781 405,438 174,850 160,828 270,327 181,796 1,902,027 444,407 298,981 352,599 865,249 166,415 438,662 -42,807 5,581 37,226 5,941 4,477 836,404 125,359 
  sales, general and administrative                                                                                      
  total operating expenses1,043,075 498,564 305,600 585,439 1,221,830 624,734 554,570 747,778 -950,626 -466,008 -823,947 -969,198 -1,662,976 -999,690 -1,074,813 -793,719 -18,964,820 -1,017,963 -916,516 -990,737 -7,340,012 -2,443,979 -1,443,884 -1,194,387 -14,371,374 -2,476,900 -2,779,804 -1,520,486 -4,810,313 -1,897,771 -2,703,723 -1,962,170 -6,161,196 2,871,558 -3,747,897 -8,726,866 -17,983,176 -7,501,152 -10,944,616 -4,996,868 -8,558,209 -4,924,798 -6,910,920 -1,431,551 -2,726,917 -1,625,937 -1,927,825 1,890,560 146,009 3,618,004 1,786,169 1,530,854 2,013,325 1,322,452 1,553,702 1,306,542 1,560,311 -1,507,588 1,117,384 1,865,739 1,427,255 -4,078,088 1,557,365 1,153,585 -339,301 756,782 534,071 2,364,363 830,586 421,117 518,473 352,230 -70,000 289,163 27,935 2,526 563 91,645 153,999 26,205 44,012 41,505 121,779 355,172 112,312 163,061 
  operating income-1,184,490 -713,542 -456,308 953,197 -1,179,148 -688,654 -779,593 -911,718 772,742 -762,404 -752,948 -696,468 -1,101,504 -952,494 74,985 -599,280 -1,660,356 -645,204 -752,968 -334,208 -1,031,833 -1,931,434 -864,403 -140,687 -1,668,687 -871,258 -1,153,467 -802,633 -569,781 -903,107 -1,399,087 -1,321,351 -5,917,391 3,193,558 -3,803,724 -7,667,739 -21,966,050 -3,716,496 -8,527,219 -2,336,482 -4,457,630 -2,687,533 -4,760,775 -3,000,459 -744,066 1,617,854 2,210,531 3,413,787 7,029,119 3,897,885 5,759,966 5,338,757 7,685,680 6,195,498 5,490,235 4,827,666 5,697,915 8,051,458 4,802,126 4,063,016 5,986,702 4,694,464 4,395,446 4,653,692 4,827,490 3,123,673 3,365,500 934,556 2,697,172 2,072,950 1,352,014 1,854,741 3,410,000 687,504 -35,981 3,502 -563 -86,828 -46,555 -59,455 -79,730 50,973 -120,409 -346,548 -87,698 -160,179 
  net income-1,232,213 -777,600 -593,029 -1,992,734 -1,347,899 -2,323,685 -2,472,424 -2,692,148 -3,066,209 -826,669 -824,761 -767,327 -1,209,037 -1,009,895 13,053 -660,897 -18,745,256 -700,954 -838,103 -417,731 -7,592,119 -1,856,519 -1,008,049 -293,480 -13,827,329 -2,195,428 -2,287,910 -966,898 -3,426,017 -1,749,909 -2,453,802 -1,552,896 832,510 -4,148,733 -4,115,352 -7,973,943 -8,686,208 -6,327,724 -8,642,950 -2,390,493 -10,429,886 -2,302,031 -4,463,825 -2,812,307 -1,244,101 1,295,483 1,759,918 2,806,359 5,805,165 3,291,785 5,069,070 5,103,622 8,358,517 5,484,927 5,276,249 4,294,654 5,106,030 7,163,228 4,286,144 3,677,647 5,354,332 4,251,478 4,037,299 4,190,541 4,034,591 3,084,765 3,326,128 2,374,039 3,478,429 1,706,865 1,830,462 1,618,936 3,180,000 510,410 -98,172 3,502 -563 -409,060 -40,643 -81,579 -103,598 256 -474,449 -359,405 -99,403 -170,876 

We provide you with 20 years income statements for China Pharma stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of China Pharma stock. Explore the full financial landscape of China Pharma stock with our expertly curated income statements.

The information provided in this report about China Pharma stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.